Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RALBP1P1 is a genomic sequence classified as a pseudogene, meaning it is a DNA segment related to the protein-coding gene RALBP1 but is not translated into a functional protein[7][11]. Pseudogenes generally arise from gene duplication or retrotransposition events and lose the ability to encode functional proteins due to mutations or truncations. Therefore, RALBP1P1 does not function as a receptor, enzyme, or transporter, and is not considered a therapeutic target. There are no known biological functions, disease associations, interacting drugs, mechanisms of action, biomarker roles, or safety concerns specific to RALBP1P1. All relevant scientific data instead refer to the protein-coding gene RALBP1 (RalA binding protein 1), which is distinct and active in receptor-mediated endocytosis and related pathways[1][13][7]. The entry is considered incorrect as a therapeutic target, as it refers to a pseudogene and not a functionally relevant molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RALA binding protein 1 pseudogene 1 (RALBP1P1).